Holen Sie sich die Stockscreener-App
24.25
3.04%
-0.76
Handel nachbörslich:
24.20
-0.05
-0.21%
Schlusskurs vom Vortag:
$25.01
Offen:
$24.67
24-Stunden-Volumen:
2.91M
Relative Volume:
1.10
Marktkapitalisierung:
$2.45B
Einnahmen:
$352.57M
Nettoeinkommen (Verlust:
$-143.01M
KGV:
-13.40
EPS:
-1.81
Netto-Cashflow:
$-153.40M
1W Leistung:
-9.28%
1M Leistung:
-5.83%
6M Leistung:
+19.81%
1J Leistung:
+5.76%
1-Tages-Spanne:
$23.04
$25.19
1-Wochen-Bereich:
$23.04
$26.67
52-Wochen-Spanne:
$13.53
$35.25
Beam Therapeutics Inc Stock (BEAM) Company Profile
Firmenname
Beam Therapeutics Inc
Sektor
Branche
Telefon
857-327-8775
Adresse
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Vergleichen Sie BEAM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BEAM
Beam Therapeutics Inc
|
24.25 | 2.53B | 352.57M | -143.01M | -153.40M | -1.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Beam Therapeutics Inc Stock (BEAM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-09 | Eingeleitet | Jefferies | Buy |
| 2025-03-28 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-03-10 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-01-29 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-01-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-08 | Herabstufung | Jefferies | Buy → Hold |
| 2023-10-20 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-10-20 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-03-21 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-02-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-20 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-12-13 | Eingeleitet | Citigroup | Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2022-04-28 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-05 | Eingeleitet | Guggenheim | Buy |
| 2021-10-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Fortgesetzt | Stifel | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-11 | Eingeleitet | Redburn | Buy |
| 2021-05-04 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-03-01 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-02-16 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-01-06 | Eingeleitet | Stifel | Hold |
| 2020-08-05 | Eingeleitet | William Blair | Outperform |
| 2020-03-02 | Eingeleitet | Barclays | Overweight |
| 2020-03-02 | Eingeleitet | JP Morgan | Overweight |
| 2020-03-02 | Eingeleitet | Jefferies | Buy |
| 2020-03-02 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Beam Therapeutics Inc Aktie (BEAM) Neueste Nachrichten
Beam Therapeutics Stock Faces Pivotal Week with Key Catalysts Ahead - AD HOC NEWS
ARK Investment Acquires Significant Stake in Beam Therapeutics ( - GuruFocus
Beam to present updated data on sickle cell gene therapy at ASH meeting - Investing.com
ASH 2025: Beam Therapeutics (NASDAQ: BEAM) to share updated BEAM-101 sickle cell data - Stock Titan
Why retail investors favor Beam Therapeutics Inc. stockTrade Performance Summary & Long-Term Capital Growth Ideas - newser.com
How buybacks impact Beam Therapeutics Inc. stock value2025 Trading Recap & AI Enhanced Trading Signals - newser.com
Institutional scanner results for Beam Therapeutics Inc.Market Rally & Fast Exit Strategy with Risk Control - newser.com
AMG National Trust Bank Buys Shares of 17,007 Beam Therapeutics Inc. $BEAM - MarketBeat
What is the fair value of Beam Therapeutics Inc. stock nowWeekly Trend Summary & Community Consensus Stock Picks - newser.com
How Beam Therapeutics Inc. stock compares to market leaders2025 Market Overview & Accurate Buy Signal Alerts - newser.com
Visual analytics tools that track Beam Therapeutics Inc. performanceMarket Activity Recap & Risk Controlled Stock Pick Alerts - newser.com
Why Beam Therapeutics Inc. stock is favored by pension fundsJuly 2025 Sentiment & Fast Momentum Entry Tips - newser.com
What analyst consensus says on Beam Therapeutics Inc. stock2025 Top Gainers & Daily Volume Surge Signals - newser.com
Real time social sentiment graph for Beam Therapeutics Inc.2025 Market Overview & Expert Curated Trade Ideas - newser.com
How to monitor Beam Therapeutics Inc. with trend dashboardsStop Loss & High Accuracy Trade Signal Alerts - newser.com
Published on: 2025-11-02 01:58:11 - newser.com
Will Beam Therapeutics Inc. stock deliver long term returnsPortfolio Profit Report & Weekly Top Performers Watchlists - newser.com
Should you wait for a breakout in Beam Therapeutics Inc.Sell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Beam Therapeutics Inc. stock outperform Nasdaq indexInsider Buying & Stepwise Trade Signal Guides - newser.com
What hedge fund activity signals for Beam Therapeutics Inc. stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Published on: 2025-10-31 03:50:40 - newser.com
Visualizing Beam Therapeutics Inc. stock with heatmaps2025 Institutional Moves & Daily Chart Pattern Signals - newser.com
ETFs Investing in Beam Therapeutics Inc. Stocks - TradingView
Why retail investors pile into Beam Therapeutics Inc. stockTreasury Yields & Real-Time Volume Triggers - newser.com
Beam Therapeutics Inc. (BEAM) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Beam Therapeutics Inc. (BEAM) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Fmr Llc Sells 459 Shares of Beam Therapeutics (NASDAQ:BEAM) Stock - MarketBeat
BEAM Form 4: 459-share sale; indirect holdings include 1,139,443 - Stock Titan
Beam Therapeutics (BEAM) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - sharewise.com
Finanzdaten der Beam Therapeutics Inc-Aktie (BEAM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):